dm+d

18750111000001103

Articles

Safety in Lactation: Other immunomodulating drugs

21 September 2020Several drugs in this section (dimethyl fumerate, interferon beta, fingolimod, glatiramer, natalizumab) are used in multiple sclerosis (MS) but are not normally interchangeable as they…
Search Articles

Medicine Compliance Aid Stability

GilenyaNovartis Pharmaceuticals UK Ltd

Novartis Pharmaceuticals UK Ltd
Gilenya
Capsules 500 micrograms
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Store in airtight container and protect from moisture.
18 September 2015

Lactation Safety Information

No
Natalizumab
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
Serious adverse effects reported in adults
22 September 2020